会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • 4-Homoisotwistane derivatives
    • 4-Homoisotwistane衍生物
    • US4318925A
    • 1982-03-09
    • US132135
    • 1980-03-20
    • Toshio AtsumiYoshiaki TakebayashiMasaru FukuiHisao Yamamoto
    • Toshio AtsumiYoshiaki TakebayashiMasaru FukuiHisao Yamamoto
    • C07C235/14C07C67/00C07C231/00C07C231/12C07C235/22C07D209/48C07D295/088C07C103/37
    • C07D209/48C07D295/088
    • A new class of 4-homoisotwistane derivatives of the formula, ##STR1## wherein R.sub.1 is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, and R.sub.2 is an alkyl group, a phenyl group which may be either unsubstituted or substituted with a C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, nitro group or a halogen atom (hereinafter referred to as "an optionally substituted phenyl group"), a group of the formula, --A--OH in which A is a C.sub.1 -C.sub.3 alkylene group; a group of the formula, --A--B in which A is as defined as above and B is a halogen atom, or a group of the formula, ##STR2## in which A is as defined above and R.sub.3 and R.sub.4 are independently a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group or R.sub.3 and R.sub.4 may, when taken together with the adjacent nitrogen atom to which R.sub.3 and R.sub.4 are linked, form pyrrolidine, piperidine, morpholine, phthalimide or piperazine, which have been found to possess potent antiviral activity, are prepared, for example by reacting a compound of the formula, ##STR3## wherein R.sub.1 is as defined above and X is halogen, with a compound of the formula,R.sub.5 OYwherein R.sub.5 has the same meanings as R.sub.2 with the exception of the group of the formula --A--B wherein A and B are as defined above and Y is alkali metal.
    • 一种新的下式的4-异亮氨酸维生素衍生物,其中R1是氢原子或C1-C3烷基,R2是烷基,可以是未取代的或被C1- C3烷基,C1-C3烷氧基,硝基或卤素原子(以下称为“任选取代的苯基”),其中A为C1-C3亚烷基的式-A-OH基团; 其中A如上所定义并且B是卤素原子的式-AB,或其中A如上所定义的式(IMAGE)的基团,且R 3和R 4独立地是氢原子或 C1-C3烷基或R3和R4可以与R3和R4相连的相邻氮原子一起形成已被发现具有强抗病毒活性的吡咯烷,哌啶,吗啉,邻苯二甲酰亚胺或哌嗪,是 例如通过使下式的化合物,其中R 1如上所定义,X是卤素的化合物与下式化合物反应:其中R 5具有与R 2相同的含义, 式-AB其中A和B如上所定义,Y是碱金属。
    • 15. 发明授权
    • 2-Substituted 5-hydroxy-1H-imidazole-4-carboxamide derivatives and use
    • 2-取代的5-羟基-1H-咪唑-4-甲酰胺衍生物和用途
    • US4218457A
    • 1980-08-19
    • US940131
    • 1978-09-06
    • Toshio AtsumiYuzo TarumiNoboru Yoshida
    • Toshio AtsumiYuzo TarumiNoboru Yoshida
    • C07D233/90A61K31/415A61K31/44C07D233/32C07D403/04
    • C07D233/90
    • Compounds of the formula, ##STR1## wherein R is C.sub.2 -C.sub.17 alkyl group, C.sub.3 -C.sub.7 cycloalkyl group, 1-adamantyl group, pyridyl group, pyridine N-oxide, diphenylmethyl group, benzyl group which may or may not be substituted with nitro group, halogen atom, C.sub.1 -C.sub.3 alkyl group or C.sub.1 -C.sub.3 alkoxy group, or phenyl group which may or may not be substituted with nitro group, halogen atom, hydroxy group, C.sub.1 -C.sub.3 alkyl group, C.sub.1 -C.sub.3 alkoxy group, carboxy group, C.sub.2 -C.sub.4 alkoxycarbonyl group, phenoxycarbonyl group, carbamoyl group, N-phenylcarbamoyl group, N-adamantylcarbamoyl group, benzoylamino group, trifluoromethyl group, C.sub.2 -C.sub.4 alkanoyloxy group, 1-adamantoyloxy group or benzoyloxy group and salts thereof have an anticancer activity and an immunostimulating activity.
    • 下式的化合物,其中R是C 2 -C 17烷基,C 3 -C 7环烷基,1-金刚烷基,吡啶基,吡啶N-氧化物,二苯基甲基,可以是也可以不是 被硝基,卤原子,C1-C3烷基或C1-C3烷氧基取代的苯基,或可以被硝基,卤素原子,羟基,C1-C3烷基,C1-C3烷氧基取代的苯基 基团,羧基,C 2 -C 4烷氧基羰基,苯氧基羰基,氨基甲酰基,N-苯基氨基甲酰基,N-金刚烷基氨基甲酰基,苯甲酰氨基,三氟甲基,C 2 -C 4烷酰氧基,1-酰胺基氧基或苯甲酰氧基及其盐 抗癌活性和免疫刺激活性。
    • 17. 发明授权
    • Preparation of 2-benzoylalkylbenzomorphan
    • 2-苯甲酰基烷基苯并咪唑的制备
    • US3953441A
    • 1976-04-27
    • US150841
    • 1971-06-07
    • Toshio AtsumiKenji KobayashiYoshiaki TakebayashiHisao Yamamoto
    • Toshio AtsumiKenji KobayashiYoshiaki TakebayashiHisao Yamamoto
    • C07D211/70C07D221/26
    • C07D221/26C07D211/70
    • A novel process for preparing 2-benzoylalkylbenzomorphan derivatives and salts thereof, represented by the formula ##SPC1##Wherein n, R, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined in the specification. The process comprises reacting a pyridinium derivative of the formula, ##SPC2##Wherein X is a halogen atom and Y' is an ethylenedioxy group; with a Grignard reagent of the formula, ##SPC3##Wherein R' is a hydrogen atom or a C.sub.1 -C.sub.3 alkoxy group and Z is a halogen atom, to yield a 1,2-dihydropyridine derivative of the formula; ##SPC4##And then reducing the said 1,2-dihydropyridine derivative to give a 1,2,5,6-tetrahydropyridine derivative of the formula, ##SPC5##Wherein Y is an oxygen atom or an ethylenedioxy group, and further cyclizing the obtained 1,2,5,6-tetrahydropyridine derivative.
    • 由式WHEREIN N,R,R1,R2,R3和R4表示的用于制备2-苯甲酰基烷基苯并喃衍生物及其盐的新方法如本说明书中所定义。 该方法包括使下式的吡啶鎓衍生物WHEREIN X是卤素原子,Y'是亚乙二氧基; 与下式的格利雅试剂,其中R'是氢原子或C1-C3烷氧基,Z是卤素原子,得到下式的1,2-二氢吡啶衍生物; 然后减少所得的1,2-二氢吡啶衍生物,得到本发明的1,2,5,6-四氢吡啶衍生物,其中Y是氧原子或亚乙二氧基,进一步环化得到的1,2,5,6-四氢吡啶衍生物, 6-四氢吡啶衍生物。